Hui Li
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 23
- Immunology 57
- Immune Response and Inflammation 16
- Co-authors
- Hourong CaiCanmao XieTimothy S. BlackwellXiao HanZhisheng LiuXiaoxia LüJie RenFu-Rong Zhang
- Journals
- PLoS ONE (6 papers)Scientific Reports (5 papers)Oncotarget (5 papers)Frontiers in Microbiology (4 papers)International Immunopharmacology (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Li
288 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Molecular Medicine 742
- Cancer Research 1.6k
- Endocrinology 287
- Molecular Biology 3.1k
- Immunology 804
Countries citing papers authored by Hui Li
This map shows the geographic impact of Hui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Li more than expected).
Fields of papers citing papers by Hui Li
This network shows the impact of papers produced by Hui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Li. The network helps show where Hui Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 204 | |
| 14 | 2019 | 10 | |
| 15 | Clinical characteristics and risk factor analysis of delayed bleeding after endoscopic mucosal resection for colon polyps | 2019 | 1 |
| 16 | Novel Plasmid-Mediated Colistin Resistance Gene mcr-3 in Escherichia coli Hit paper breakdown → | 2017 | 448 |
| 17 | 2017 | 2 | |
| 18 | Effect of ethyl acetate extract from coreopsis tinctoria on diabetic SD rats induced by STZ | 2015 | 2 |
| 19 | 2014 | 62 | |
| 20 | 2011 | 35 |
About Hui Li
Hui Li is a scholar working on Cancer Research, Immunology, Pulmonary and Respiratory Medicine, Molecular Medicine and Oncology, having authored 302 papers that have together received 7.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (23 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Circular RNAs in diseases (17 papers), Immune Response and Inflammation (16 papers), RNA modifications and cancer (13 papers), COVID-19 Clinical Research Studies (11 papers) and Neonatal Respiratory Health Research (8 papers). The work is most often cited by research in Molecular Medicine (742 citations), Cancer Research (1.6k citations), Endocrinology (287 citations), Molecular Biology (3.1k citations) and Immunology (804 citations). Hui Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hourong Cai, Canmao Xie, Timothy S. Blackwell, Xiao Han, Zhisheng Liu, Xiaoxia Lü, Jie Ren, Fu-Rong Zhang, Dan Sun and Yifeng Luo. Their work appears in journals such as PLoS ONE, Scientific Reports, Oncotarget, Frontiers in Microbiology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.